Plant stanols and asthma symptoms prevention
Part of Heart & circulation, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether eating plant stanols (a natural substance found in some foods) can help prevent asthma symptoms in people with stable allergic asthma. You would need to take a daily chew and avoid certain cholesterol-lowering products during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with allergic asthma that is well-controlled and stable for the past 3 months.
- You have been using asthma medication for at least 1 year.
- You are between 18 and 70 years old.
- Your BMI is between 20 and 35.
- You agree not to eat any foods with added plant sterols or stanols (like certain margarines or yogurt drinks) for 1 month before and during the study.
- You agree to keep your fish oil supplement intake the same during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study looks at how asthma-related inflammation works and whether a diet-related approach could help. It may be most relevant if you have confirmed asthma and can follow the study’s diet requirements.
This trial tests if a daily supplement called astaxanthin can help people with mild-to-moderate asthma, especially in areas with more air pollution. You would take capsules and track your breathing at home.
This trial tests whether taking ginger supplements can improve asthma control for adults whose symptoms are not well managed with their current inhaled steroids. If you have persistent asthma and are already using an inhaled steroid, this study may help see if ginger can reduce your symptoms.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.